Bio-Works Technologies AB (FRA:1BD) Minority Interest: €0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1BD Bio-Works Technologies AB FRA:1BD
49 GF Score
Price €0.29
GF Value €0.32
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bio-Works Technologies AB Minority Interest?

Bio-Works Technologies AB FRA:1BD +5.93% 49 Minority Interest is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:1BD with a GF Score™ of 49/100 and a GF Value™ of €0.32 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Bio-Works Technologies AB's minority interest for the quarter that ended in Mar. 2026 was €0.00 Mil.

Bio-Works Technologies AB Minority Interest Historical Data

* Premium members only.

The historical data trend for Bio-Works Technologies AB's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Works Technologies AB Minority Interest Chart

Bio-Works Technologies AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Minority Interest
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bio-Works Technologies AB Quarterly Data
Dec19 Mar20 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:1BD
49GF Score
Bio-Works Technologies AB FRA:1BD
Minority Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Works Technologies AB Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Frequently Asked Questions Learn more about Minority Interest →
What does a Minority Interest of €0.00 Mil mean?
Bio-Works Technologies AB (FRA:1BD) has a Minority Interest of €0.00 Mil as of Mar. 2026. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Bio-Works Technologies AB.
Is Bio-Works Technologies AB's Minority Interest too high?
Bio-Works Technologies AB's current Minority Interest is €0.00 Mil. Overall, Bio-Works Technologies AB has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bio-Works Technologies AB's Minority Interest compare to ISRG and BDX?
Bio-Works Technologies AB's Minority Interest of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Minority Interest for a Medical Devices & Instruments company?
A good Minority Interest depends on the Medical Devices & Instruments industry context. However, Minority Interest should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Minority Interest mean?
A high Minority Interest can signal that a stock is expensive relative to its fundamentals. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Bio-Works Technologies AB. Bio-Works Technologies AB's current Minority Interest is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Works Technologies AB stock overvalued right now?
Based on GuruFocus' analysis, Bio-Works Technologies AB (FRA:1BD) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.32, compared to a current price of €0.29 — trading 10.3% below its estimated fair value. The current Minority Interest is €0.00 Mil. Bio-Works Technologies AB's overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Minority Interest calculated?
Minority Interest is calculated from a company's financial statements. For Bio-Works Technologies AB (FRA:1BD), the current Minority Interest is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Works Technologies AB (FRA:1BD) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Works Technologies AB stock appears to be undervalued. The current stock price of €0.29 is trading 10.3% below its estimated GF Value™ of €0.32. GuruFocus considers Bio-Works Technologies AB to be Modestly Undervalued.

Key valuation signals for FRA:1BD:

  • Minority Interest: €0.00 Mil
  • GF Value™: €0.32 vs. price of €0.29 (10.3% below fair value)
  • GF Score™: 49/100 with 2 warning signs

No single metric tells the full story. See the FRA:1BD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Works Technologies AB Business Description

Other Exchanges BIOWKS:Sweden
Address Virdings alle 18, Uppsala, SWE, 75450
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.
49GF Score

Get the complete analysis for FRA:1BD

Minority Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.29
Price
€0.32
GF Value